These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2533407)

  • 1. [Chronic myeloid leukemia and carcinoma of the prostate].
    Papineschi F; Bonini R; Pistolisi D; Spremolla G
    Sangre (Barc); 1989 Oct; 34(5):383. PubMed ID: 2533407
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cyproterone acetate and cancer of the prostate. Experience in 46 cases].
    Tauveron I; Hermabessière J
    Therapie; 1988 May; 43(3):175-7. PubMed ID: 2971277
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hypercalcemia: a finding indicative of a prostatic adenocarcinoma].
    Llarena Ibarguren R; Acha Pérez M; Zabala Egurrola JA; Pertusa Peña C
    Actas Urol Esp; 1989; 13(5):409-10. PubMed ID: 2531967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyproterone acetate in the management of prostatic cancer.
    Tunn UW
    Prog Clin Biol Res; 1989; 303():105-10. PubMed ID: 2528734
    [No Abstract]   [Full Text] [Related]  

  • 5. [Brain metastasis of prostatic cancer: regression under hormonal treatment].
    Ameur A; Touiti D; el Mostarchid B; el Alami M; Jira H; Abbar M
    Prog Urol; 2001 Dec; 11(6):1298-301. PubMed ID: 11859670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advantages and disadvantages of pure antiandrogens and of antiandrogens of the cyproterone acetate-type in the treatment of prostatic cancer.
    Habenicht UF; Schröder H; el Etreby MF; Neumann F
    Prog Clin Biol Res; 1988; 260():63-75. PubMed ID: 2966407
    [No Abstract]   [Full Text] [Related]  

  • 7. New forms and future perspectives in endocrine treatment of prostatic carcinoma.
    Jacobi GH; Wenderoth UK
    Prog Clin Biol Res; 1984; 153():529-45. PubMed ID: 6236463
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cyproterone acetate in the treatment of post-orchiectomy flushing].
    Jansen JE; Hendriksen ON
    Ugeskr Laeger; 1989 Feb; 151(9):560-1. PubMed ID: 2522257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The development of metachronous prostate cancer and chronic myeloid leukemia in a patient with metastatic rectal cancer.
    Oztop I; Yaren A; Demirpence M; Alacacioglu I; Tuna B; Piskin O; Yilmaz U
    J BUON; 2008; 13(2):267-70. PubMed ID: 18555476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response of prostate cancer during imatinib therapy in a patient with chronic myeloid leukemia.
    Breccia M; De Cuia MR; D'Elia GM; Francesca B; Mandelli F; Alimena G
    Haematologica; 2004 Jul; 89(7):ECR20. PubMed ID: 15257957
    [No Abstract]   [Full Text] [Related]  

  • 11. [Chronic myeloid leukemia in hemophilia B].
    Larraín C
    Rev Med Chil; 2002 Aug; 130(8):897-900. PubMed ID: 12360799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Busulfan versus busulfan-interferon as maintenance therapy in chronic myeloid leukemia].
    López Hernández MA; Flores-Chapa JD; Trueba Christy E; Borbolla Escoboza JR; Carrillo Rosales T
    Rev Invest Clin; 1996; 48(4):281-7. PubMed ID: 8966391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Zoladex, diethylstilbestrol and cyproterone acetate treatment in advanced prostate cancer.
    Moffat LE
    Eur Urol; 1990; 18 Suppl 3():26-7. PubMed ID: 2151272
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapy of virginal prostatic cancer with cyproterone acetate].
    Maier U
    Z Urol Nephrol; 1985 Apr; 78(4):181-7. PubMed ID: 3160180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Endometrioid carcinoma of the prostate: a histogenetic dilemma with therapeutic implications].
    Angulo Cuesta J; López JI; Unda Urzaiz M; Eizaguirre Zarza B; Flores Corral N
    Arch Esp Urol; 1990; 43(9):979-81. PubMed ID: 2151109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chronic myeloid leukemia (CML) and solid neoplasms. Description of 3 cases].
    Franco E; Alvarez R; Cuesta I; Aguilar C
    Sangre (Barc); 1994 Feb; 39(1):59-60. PubMed ID: 8197522
    [No Abstract]   [Full Text] [Related]  

  • 17. Subcutaneous leukaemic deposit in chronic myelogenous leukaemia--course and histological appearance.
    Misra RC; Rakshit MM; Basu AK
    J Assoc Physicians India; 1973 Jul; 21(7):623-5. PubMed ID: 4283781
    [No Abstract]   [Full Text] [Related]  

  • 18. Haemopericardium with cardiac tamponade and pleural effusion in chronic myeloid leukemia.
    Mohapatra MK; Das SP; Mohanty NC; Dash PC; Bastia BK
    Indian Heart J; 2000; 52(2):209-11. PubMed ID: 10893903
    [No Abstract]   [Full Text] [Related]  

  • 19. The position of cyproterone acetate (CPA), a steroidal anti-androgen, in the treatment of prostate cancer.
    de Voogt HJ
    Prostate Suppl; 1992; 4():91-5. PubMed ID: 1533452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytogenetic response to pipobroman in Philadelphia-positive chronic myeloid leukemia with thrombocythemic onset.
    Orlandi E; Bernasconi P; Boni M; Calatroni S; Lazzarino M
    Ann Hematol; 2005 Feb; 84(2):127-8. PubMed ID: 15378276
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.